112 related articles for article (PubMed ID: 15887291)
1. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
2. Histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of patient with testicular embryonal cancer.
Suekane S; Nakao M; Inoue M; Noda S; Itoh K
Jpn J Cancer Res; 1997 Dec; 88(12):1181-9. PubMed ID: 9473736
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas.
Dersh D; Phelan JD; Gumina ME; Wang B; Arbuckle JH; Holly J; Kishton RJ; Markowitz TE; Seedhom MO; Fridlyand N; Wright GW; Huang DW; Ceribelli M; Thomas CJ; Lack JB; Restifo NP; Kristie TM; Staudt LM; Yewdell JW
Immunity; 2021 Jan; 54(1):116-131.e10. PubMed ID: 33271120
[TBL] [Abstract][Full Text] [Related]
4. Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy.
Méndez R; Ruiz-Cabello F; Rodríguez T; Del Campo A; Paschen A; Schadendorf D; Garrido F
Cancer Immunol Immunother; 2007 Jan; 56(1):88-94. PubMed ID: 16622680
[TBL] [Abstract][Full Text] [Related]
5. Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell Lymphomas.
Wang X; Waschke BC; Woolaver RA; Chen Z; Zhang G; Piscopio AD; Liu X; Wang JH
Cancer Immunol Res; 2019 Aug; 7(8):1318-1331. PubMed ID: 31235619
[TBL] [Abstract][Full Text] [Related]
6. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
Fangazio M; Ladewig E; Gomez K; Garcia-Ibanez L; Kumar R; Teruya-Feldstein J; Rossi D; Filip I; Pan-Hammarström Q; Inghirami G; Boldorini R; Ott G; Staiger AM; Chapuy B; Gaidano G; Bhagat G; Basso K; Rabadan R; Pasqualucci L; Dalla-Favera R
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050029
[TBL] [Abstract][Full Text] [Related]
7. HLA-class-I expression loss, tumor microenvironment and breast cancer prognosis.
Giatromanolaki A; Michos GD; Xanthopoulou E; Koukourakis MI
Cell Immunol; 2024; 399-400():104816. PubMed ID: 38507936
[TBL] [Abstract][Full Text] [Related]
8. Tumour escape: antitumour effectors too much of a good thing?
Pawelec G
Cancer Immunol Immunother; 2004 Mar; 53(3):262-74. PubMed ID: 14685780
[TBL] [Abstract][Full Text] [Related]
9. Immunopathology of in situ seminoma.
Bols B; Jensen L; Jensen A; Braendstrup O
Int J Exp Pathol; 2000 Jun; 81(3):211-7. PubMed ID: 10971742
[TBL] [Abstract][Full Text] [Related]
10. Association between brain cancer immunogenetic profile and in silico immunogenicities of 11 viruses.
Georgopoulos AP; James LM
Sci Rep; 2023 Dec; 13(1):21528. PubMed ID: 38057480
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.
Schwindt H; Vater I; Kreuz M; Montesinos-Rongen M; Brunn A; Richter J; Gesk S; Ammerpohl O; Wiestler OD; Hasenclever D; Deckert M; Siebert R
Leukemia; 2009 Oct; 23(10):1875-84. PubMed ID: 19494841
[TBL] [Abstract][Full Text] [Related]
12. The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults.
Shi ZF; Li KK; Liu AP; Chung NY; Wong SC; Chen H; Woo PY; Chan DT; Mao Y; Ng HK
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730692
[TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy.
Roschewski M; Hodson DJ
Haematologica; 2024 Feb; 109(2):388-400. PubMed ID: 37706315
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review.
Perdikis-Prati S; Sheikh S; Bouroumeau A; Lang N
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371815
[TBL] [Abstract][Full Text] [Related]
15. The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
[TBL] [Abstract][Full Text] [Related]
16. CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma.
Higashi M; Momose S; Takayanagi N; Tanaka Y; Anan T; Yamashita T; Kikuchi J; Tokuhira M; Kizaki M; Tamaru JI
J Pathol Clin Res; 2022 Jul; 8(4):340-354. PubMed ID: 35289116
[TBL] [Abstract][Full Text] [Related]
17. A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Güney E; Lucas CG; Qi Z; Yu J; Zhang R; Ohgami RS; Rubenstein JL; Boué DR; Schafernak K; Wertheim GB; Dahiya S; Giulino-Roth L; Attarbaschi A; Barth MJ; Kothari S; Abla O; Cohen AL; Mendez JS; Bollen A; Perry A; Tihan T; Pekmezci M; Solomon DA; Wen KW
Blood Adv; 2022 May; 6(10):3189-3193. PubMed ID: 35157770
[No Abstract] [Full Text] [Related]
18. Primary Testicular Lymphoma with Central Nervous System Relapse Was Successfully Treated by a Chemo-Free Regimen: A Case Report and Literature Review.
Yan Z; Yao S; Wang Y; Liu Y; Yao Z
Cancer Manag Res; 2021; 13():9489-9500. PubMed ID: 35002326
[TBL] [Abstract][Full Text] [Related]
19. Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System.
Montesinos-Rongen M; Brunn A; Sanchez-Ruiz M; Küppers R; Siebert R; Deckert M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944954
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
